Veracyte Director Karin Eastham Executes Stock Sales Under Pre-Existing Trading Plan
Veracyte, Inc. director Karin Eastham completed a series of stock sales totaling $197,234 on June 18, 2026. The transactions were facilitated through a Rule 10b5-1 trading plan adopted in September 2025. This activity occurs as Veracyte's shares trade near a 52-week high of $53.81, reflecting a 103% gain over the past year. Concurrently, the diagno…